Kelvin Kai‐Wang To

55.5k total citations · 11 hit papers
316 papers, 19.2k citations indexed

About

Kelvin Kai‐Wang To is a scholar working on Infectious Diseases, Epidemiology and Immunology. According to data from OpenAlex, Kelvin Kai‐Wang To has authored 316 papers receiving a total of 19.2k indexed citations (citations by other indexed papers that have themselves been cited), including 194 papers in Infectious Diseases, 146 papers in Epidemiology and 43 papers in Immunology. Recurrent topics in Kelvin Kai‐Wang To's work include SARS-CoV-2 and COVID-19 Research (109 papers), Influenza Virus Research Studies (74 papers) and Respiratory viral infections research (68 papers). Kelvin Kai‐Wang To is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (109 papers), Influenza Virus Research Studies (74 papers) and Respiratory viral infections research (68 papers). Kelvin Kai‐Wang To collaborates with scholars based in Hong Kong, China and United Kingdom. Kelvin Kai‐Wang To's co-authors include Kwok‐Yung Yuen, Jasper Fuk‐Woo Chan, Vincent Chi‐Chung Cheng, Hin Chu, Kwok‐Hung Chan, Kin‐Hang Kok, Shuofeng Yuan, Ivan Fan‐Ngai Hung, Zheng Zhu and Honglin Chen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Medicine and Nature Communications.

In The Last Decade

Kelvin Kai‐Wang To

310 papers receiving 18.7k citations

Hit Papers

Genomic characterization of the 2019 no... 2013 2026 2017 2021 2020 2020 2015 2020 2020 500 1000 1.5k 2.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan
    2020 2.1k citations Jasper Fuk‐Woo Chan, Kin‐Hang Kok et al. profile →
  2. Consistent Detection of 2019 Novel Coronavirus in Saliva
    2020 1.3k citations Kelvin Kai‐Wang To, Owen Tak-Yin Tsang et al. profile →
  3. Middle East Respiratory Syndrome Coronavirus: Another Zoonotic Betacoronavirus Causing SARS-Like Disease
    2015 653 citations Jasper Fuk‐Woo Chan, Kelvin Kai‐Wang To et al. profile →
  4. Improved Molecular Diagnosis of COVID-19 by the Novel, Highly Sensitive and Specific COVID-19-RdRp/Hel Real-Time Reverse Transcription-PCR Assay Validated In Vitro and with Clinical Specimens
    2020 651 citations Jasper Fuk‐Woo Chan, Cyril Chik‐Yan Yip et al. profile →
  5. The role of community-wide wearing of face mask for control of coronavirus disease 2019 (COVID-19) epidemic due to SARS-CoV-2
    2020 599 citations Vincent Chi‐Chung Cheng, Shuk‐Ching Wong et al. Journal of Infection profile →
  6. Coronavirus Disease 2019 (COVID-19) Re-infection by a Phylogenetically Distinct Severe Acute Respiratory Syndrome Coronavirus 2 Strain Confirmed by Whole Genome Sequencing
    2020 449 citations Kelvin Kai‐Wang To, Ivan Fan‐Ngai Hung et al. profile →
  7. Interspecies transmission and emergence of novel viruses: lessons from bats and birds
    2013 414 citations Jasper Fuk‐Woo Chan, Kelvin Kai‐Wang To et al. profile →
  8. Surgical Mask Partition Reduces the Risk of Noncontact Transmission in a Golden Syrian Hamster Model for Coronavirus Disease 2019 (COVID-19)
    2020 400 citations Jasper Fuk‐Woo Chan, Shuofeng Yuan et al. profile →
  9. Active Replication of Middle East Respiratory Syndrome Coronavirus and Aberrant Induction of Inflammatory Cytokines and Chemokines in Human Macrophages: Implications for Pathogenesis
    2013 330 citations Hin Chu, Jasper Fuk‐Woo Chan et al. profile →
  10. SARS-CoV-2 Omicron variant shows less efficient replication and fusion activity when compared with Delta variant in TMPRSS2-expressed cells
    2021 257 citations Lu Lu, Lin‐Lei Chen et al. profile →
  11. Lessons learned 1 year after SARS-CoV-2 emergence leading to COVID-19 pandemic
    2021 211 citations Kelvin Kai‐Wang To, Siddharth Sridhar et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kelvin Kai‐Wang To Hong Kong 64 12.3k 4.3k 2.5k 2.0k 1.8k 316 19.2k
Vincent Chi‐Chung Cheng China 68 14.4k 1.2× 5.2k 1.2× 2.1k 0.8× 1.0k 0.5× 1.8k 1.0× 369 23.1k
Dayan Wang China 31 13.4k 1.1× 5.0k 1.1× 2.4k 0.9× 1.5k 0.7× 3.4k 1.9× 200 23.0k
Weifeng Shi China 39 15.4k 1.3× 3.4k 0.8× 2.9k 1.2× 1.3k 0.7× 3.6k 2.0× 212 25.7k
Kwok‐Hung Chan Hong Kong 74 15.8k 1.3× 6.0k 1.4× 2.0k 0.8× 1.8k 0.9× 1.5k 0.8× 223 23.0k
Bart L. Haagmans Netherlands 74 17.2k 1.4× 4.1k 1.0× 3.5k 1.4× 2.5k 1.3× 2.2k 1.3× 245 24.6k
Vincent J. Munster United States 63 14.9k 1.2× 10.2k 2.4× 2.5k 1.0× 2.2k 1.1× 1.5k 0.8× 219 23.0k
Xuejun Ma China 29 13.1k 1.1× 2.2k 0.5× 2.4k 1.0× 928 0.5× 3.4k 1.9× 138 21.4k
Xingwang Li China 18 12.2k 1.0× 2.2k 0.5× 2.0k 0.8× 1.1k 0.5× 3.4k 1.9× 54 20.4k
Ivan Fan‐Ngai Hung Hong Kong 55 6.9k 0.6× 4.6k 1.1× 1.2k 0.5× 1.0k 0.5× 1.3k 0.7× 311 13.6k
Zheng‐Li Shi China 53 17.7k 1.4× 2.1k 0.5× 3.5k 1.4× 2.4k 1.2× 2.2k 1.2× 246 23.8k

Countries citing papers authored by Kelvin Kai‐Wang To

Since Specialization
Citations

This map shows the geographic impact of Kelvin Kai‐Wang To's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kelvin Kai‐Wang To with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kelvin Kai‐Wang To more than expected).

Fields of papers citing papers by Kelvin Kai‐Wang To

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kelvin Kai‐Wang To. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kelvin Kai‐Wang To. The network helps show where Kelvin Kai‐Wang To may publish in the future.

Co-authorship network of co-authors of Kelvin Kai‐Wang To

This figure shows the co-authorship network connecting the top 25 collaborators of Kelvin Kai‐Wang To. A scholar is included among the top collaborators of Kelvin Kai‐Wang To based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kelvin Kai‐Wang To. Kelvin Kai‐Wang To is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Ying, Shaofeng Deng, Shuang Ren, et al.. (2025). Intranasal influenza virus-vectored vaccine offers protection against clade 2.3.4.4b H5N1 infection in small animal models. Nature Communications. 16(1). 3133–3133. 3 indexed citations
2.
Yip, Cyril Chik‐Yan, Kit‐Hang Leung, Wan-Mui Chan, et al.. (2024). Development and Evaluation of an In-House Real-Time RT-PCR Targeting nsp10 Gene for SARS-CoV-2 Detection. International Journal of Molecular Sciences. 25(6). 3552–3552. 1 indexed citations
3.
Morano, Nicholas C., Haijuan Du, Kwok‐Yung Yuen, et al.. (2024). Human neutralizing antibodies target a conserved lateral patch on H7N9 hemagglutinin head. Nature Communications. 15(1). 4505–4505. 4 indexed citations
4.
Ong, Chon Phin, Zi‐Wei Ye, Chi‐Ping Chan, et al.. (2024). Nsp1 facilitates SARS-CoV-2 replication through calcineurin-NFAT signaling. mBio. 15(4). e0039224–e0039224.
5.
Wong, Shuk‐Ching, Jonathan Hon-Kwan Chen, Pui Hing Chau, et al.. (2024). Tracking SARS-CoV-2 RNA in the air: Lessons from a COVID-19 outbreak in an infirmary unit. American Journal of Infection Control. 53(3). 348–356. 1 indexed citations
6.
Ip, Jonathan Daniel, Wan-Mui Chan, Allen Wing‐Ho Chu, et al.. (2024). The significance of recurrent de novo amino acid substitutions that emerged during chronic SARS-CoV-2 infection: an observational study. EBioMedicine. 107. 105273–105273. 1 indexed citations
7.
Ng, Pauline Yeung, et al.. (2024). Risk of acute kidney injury in critically-ill patients with COVID-19 compared with seasonal influenza: a retrospective cohort study. EClinicalMedicine. 70. 102535–102535. 5 indexed citations
8.
Cai, Jian‐Piao, Anthony Raymond Tam, Kun Wang, et al.. (2023). Determination of seroprevalence and kinetics of humoral response using mpox virus A29 protein. SHILAP Revista de lepidopterología. 3(1). 168–168. 4 indexed citations
9.
10.
Lui, David Tak Wai, Chi‐Ho Lee, Chloe Y. Y. Cheung, et al.. (2023). A prospective follow-up on thyroid function, thyroid autoimmunity and long COVID among 250 COVID-19 survivors. Endocrine. 80(2). 380–391. 17 indexed citations
11.
Cai, Jian‐Piao, Jianwen Situ, Man Lung Yeung, et al.. (2023). Autoantibodies against angiotensin‐converting enzyme 2 (ACE2) after COVID‐19 infection or vaccination. Journal of Medical Virology. 95(12). e29313–e29313. 6 indexed citations
12.
Fung, Matrix Man Him, David Tak Wai Lui, K.W. Chiu, et al.. (2023). A prospective follow-up of thyroid volume and thyroiditis features on ultrasonography among survivors of predominantly mild to moderate COVID-19. PeerJ. 11. e15034–e15034. 2 indexed citations
13.
Chen, Lin‐Lei, Syed Muhammad Abdullah, Wan-Mui Chan, et al.. (2022). Contribution of low population immunity to the severe Omicron BA.2 outbreak in Hong Kong. Nature Communications. 13(1). 3618–3618. 41 indexed citations
14.
Lui, David Tak Wai, Chi‐Ho Lee, Wing Chow, et al.. (2021). Insights from a Prospective Follow-up of Thyroid Function and Autoimmunity among COVID-19 Survivors. Endocrinology and Metabolism. 36(3). 582–589. 35 indexed citations
15.
Zhang, Ruiqi, Danlei Liu, Yujing Fan, et al.. (2021). Antibody Response of BNT162b2 and CoronaVac Platforms in Recovered Individuals Previously Infected by COVID-19 against SARS-CoV-2 Wild Type and Delta Variant. Vaccines. 9(12). 1442–1442. 16 indexed citations
16.
Wang, Xiaohui, Jian‐Piao Cai, Shannon Wing‐Ngor Au, et al.. (2020). Accurate Diagnosis of COVID-19 by a Novel Immunogenic Secreted SARS-CoV-2 orf8 Protein. mBio. 11(5). 46 indexed citations
17.
Zhou, Runhong, Kelvin Kai‐Wang To, Michael Yik-Chun Wong, et al.. (2020). Acute SARS-CoV-2 Infection Impairs Dendritic Cell and T Cell Responses. Immunity. 53(4). 864–877.e5. 346 indexed citations
18.
To, Kelvin Kai‐Wang, Ivan Fan‐Ngai Hung, Jasper Fuk‐Woo Chan, & Kwok‐Yung Yuen. (2015). From SARS coronavirus to novel animal and human coronaviruses. ASVIDE. 1(1). 34 indexed citations
19.
To, Kelvin Kai‐Wang, Alan K. L. Tsang, Jasper Fuk‐Woo Chan, et al.. (2014). Emergence in China of human disease due to avian influenza A(H10N8) – Cause for concern?. Journal of Infection. 68(3). 205–215. 85 indexed citations
20.
Chan, Jasper Fuk‐Woo, Kenneth S. M. Li, Kelvin Kai‐Wang To, et al.. (2012). Is the discovery of the novel human betacoronavirus 2c EMC/2012 (HCoV-EMC) the beginning of another SARS-like pandemic?. Journal of Infection. 65(6). 477–489. 127 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vincent Chi‐Chung Cheng Breakdown of academic impact, for papers by Dayan Wang Breakdown of academic impact, for papers by Weifeng Shi Breakdown of academic impact, for papers by Kwok‐Hung Chan Breakdown of academic impact, for papers by Bart L. Haagmans Breakdown of academic impact, for papers by Vincent J. Munster Breakdown of academic impact, for papers by Xuejun Ma Breakdown of academic impact, for papers by Xingwang Li Breakdown of academic impact, for papers by Ivan Fan‐Ngai Hung Breakdown of academic impact, for papers by Zheng‐Li Shi
Rankless by CCL
2026